Metropolitan Life Insurance CO X4 Pharmaceuticals, Inc Transaction History
Metropolitan Life Insurance CO
- $341 Million
- Q3 2025
Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
11Shares Held
13.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY10.7MShares$39.1 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD2.23MShares$8.18 Million0.47% of portfolio
-
Sv Health Investors, LLC Boston, MA311KShares$1.14 Million1.65% of portfolio
-
Acorn Capital Advisors, LLC New York, NY273KShares$1 Million0.47% of portfolio
-
Ajo Vista, LLC Boston, MA258KShares$942,9770.75% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $251M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...